Susp. Magnogel
Oral Suspension · Oral · (175mg + 225mg) / 5 ml · 200 ml
৳32
Susp.
Magnogel
Aluminium Hydroxide + Magnesium Hydroxide
— Amico Laboratories Ltd.
(175mg + 225mg) / 5 ml
· 200 ml
Presentation
Dose rules
No structured dose rules are linked to this brand yet.
Dose reference
Human
Tablet: Two tablets 1-3 hours after meal and at bed time or as directed by the physician.Suspension: 2 tea spoonful 1-3 hours after meal and at bed time or as directed by the physician.
Clinical notes
Applications:
N/A
Indication Notes:
Aluminium Hydroxide and Magnesium Hydroxide is indicated for Hyperacidity, peptic ulcer, gastritis, heartburn, sour stomach & dyspepsia.
Avoid In:
N/A
Contraindication Notes:
This is contraindicated in hypophosphataemia. It is also contraindicated in alkalosis and hypermagnesaemia where abdominal distention may be due to partial or complete intestinal obstruction.
This drug is well-balanced combination of essential non-systemic antacids which excel in efficacy and palatability. These are dependable antacid preparations without acid rebound, constipating or cathertic effects. Both the preparations provide symptomatic relief of hyperacidity associated with heartburn, acid ingestion or sour stomach.Aluminium hydroxide gel, a slow acting antacid and an adsorbent with prolonged effect, has high neutralizing power. Magnesium Hydroxide possesses a slow but sustained acid neutralizing property. Antacids of both tablet and suspension possess adsorbent property. They form a protecting coating over the ulcer surface facilitating its healing; thus protecting the sensitive mucosa of stomach and duodenum from further irritation.
This drug inhibits the absorption of following drugs: Azithromycin, cefpodoxime, ciprofloxacin, isoniazid, rifampicin, norfloxacin, ofloxacin, pivampicillin, tetracyclines, Gabapentin and phenytoin, Itraconazole, ketoconazole, Chloroquine, hydroxychloroquine and Phenothiazines.
Long term use of any antacid results in alkaluria, which may predispose to nephrolithiasis by forming precipitation of calcium phosphate.
It is advised to avoid antacid preparations in the first trimester of pregnancy.
Antacids reduce the absorption of tetracycline when given concomitantly. These should not be used concomitantly